Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Treace Medical Concepts I...

    NASDAQ: TMCI · Real-Time Price · USD
    5.74
    0.07 (1.23%)
    At close: Jun 16, 2025, 3:59 PM
    5.76
    0.44%
    After-hours: Jun 16, 2025, 04:04 PM EDT

    Treace Medical Concepts Statistics

    Share Statistics

    Treace Medical Concepts has 62.91M shares outstanding. The number of shares has increased by 0.98% in one year.

    Shares Outstanding

    n/a
    		 62.91M

    Shares Change (YoY)

    n/a
    		 0.98%

    Shares Change (QoQ)

    n/a
    		 0.52%

    Owned by Institutions (%)

    n/a
    		 59.95%

    Shares Floating

    n/a
    		 44.63M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,812

    FTD / Avg. Volume

    n/a
    		 0.42%

    Short Selling Information

    The latest short interest is 2.68M, so 4.26% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.68M

    Short % of Shares Out

    n/a
    		 4.26%

    Short % of Float

    n/a
    		 5.62%

    Short Ratio (days to cover)

    n/a
    		 7.03

    Valuation Ratios

    The PE ratio is -8.29 and the forward PE ratio is -8.93. Treace Medical Concepts's PEG ratio is -0.75.

    PE Ratio

    n/a
    		 -8.29

    Forward PE

    n/a
    		 -8.93

    PS Ratio

    n/a
    		 2.21

    Forward PS

    n/a
    		 1.1

    PB Ratio

    n/a
    		 4.09

    P/FCF Ratio

    n/a
    		 -9.48

    PEG Ratio

    n/a
    		 -0.75
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Treace Medical Concepts.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.62.

    Current Ratio

    n/a
    		 4.62

    Quick Ratio

    n/a
    		 3.5

    Debt / Equity

    n/a
    		 0.62

    Debt / EBITDA

    n/a
    		 -1.66

    Debt / FCF

    n/a
    		 -1.43

    Interest Coverage

    n/a
    		 -10.6

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $438,903.56

    Profits Per Employee

    n/a
    		 $-116,861.64

    Employee Count

    n/a
    		 477

    Asset Turnover

    n/a
    		 0.96

    Inventory Turnover

    n/a
    		 1.05

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -6.12% in the last 52 weeks. The beta is 0.69, so Treace Medical Concepts's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.69

    52-Week Price Change

    n/a
    		 -6.12%

    50-Day Moving Average

    n/a
    		 6.61

    200-Day Moving Average

    n/a
    		 7.24

    Relative Strength Index (RSI)

    n/a
    		 35.17

    Average Volume (20 Days)

    n/a
    		 427,500

    Income Statement

    In the last 12 months, Treace Medical Concepts had revenue of 209.36M and earned -55.74M in profits. Earnings per share was -0.9.

    Revenue

    n/a
    		 209.36M

    Gross Profit

    n/a
    		 168.26M

    Operating Income

    n/a
    		 -55.69M

    Net Income

    n/a
    		 -55.74M

    EBITDA

    n/a
    		 -42.07M

    EBIT

    n/a
    		 -50.49M

    Earnings Per Share (EPS)

    n/a
    		 -0.9
    Full Income Statement

    Balance Sheet

    The company has 11.35M in cash and 69.65M in debt, giving a net cash position of -58.3M.

    Cash & Cash Equivalents

    n/a
    		 11.35M

    Total Debt

    n/a
    		 69.65M

    Net Cash

    n/a
    		 -58.3M

    Retained Earnings

    n/a
    		 -189.99M

    Total Assets

    n/a
    		 205.85M

    Working Capital

    n/a
    		 116.26M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -37.17M and capital expenditures -11.59M, giving a free cash flow of -48.76M.

    Operating Cash Flow

    n/a
    		 -37.17M

    Capital Expenditures

    n/a
    		 -11.59M

    Free Cash Flow

    n/a
    		 -48.76M

    FCF Per Share

    n/a
    		 -0.79
    Full Cash Flow Statement

    Margins

    Gross margin is 80.37%, with operating and profit margins of -26.6% and -26.63%.

    Gross Margin

    n/a
    		 80.37%

    Operating Margin

    n/a
    		 -26.6%

    Pretax Margin

    n/a
    		 -26.63%

    Profit Margin

    n/a
    		 -26.63%

    EBITDA Margin

    n/a
    		 -20.09%

    EBIT Margin

    n/a
    		 -26.6%

    FCF Margin

    n/a
    		 -23.29%

    Dividends & Yields

    TMCI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TMCI is $8, which is 40.8% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $8

    Price Target Difference

    n/a
    		 40.8%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 1.74

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist